Phosphodiesterase 4 inhibitors : apremilast and roflumilast

Garry G. Graham; Kevin D. Pile

doi:10.1007/978-3-7643-8550-7_56

Phosphodiesterase 4 inhibitors : apremilast and roflumilast

Garry G. Graham, Kevin D. Pile

Western Sydney University

Research output: Chapter in Book / Conference Paper › Chapter

Abstract

![CDATA[Inhibitors of phosphodiesterase 4 (PDE4) are anti-inflammatory drugs that have been evaluated for the treatment of several inflammatory diseases. The major clinically useful members of this group are apremilast and roflumilast.]]

Original language	English
Title of host publication	Compendium of Inflammatory Diseases
Editors	Michael J. Parnham
Place of Publication	Switzerland
Publisher	Springer
Pages	1079-1084
Number of pages	6
ISBN (Electronic)	9783764385507
ISBN (Print)	9783764385309
DOIs	https://doi.org/10.1007/978-3-7643-8550-7_56
Publication status	Published - 2016

Keywords

phosphodiesterases
anti-inflammatory agents

Access to Document

10.1007/978-3-7643-8550-7_56

Cite this

@inbook{5006be25ab714aa9b608cc8552104686,

title = "Phosphodiesterase 4 inhibitors : apremilast and roflumilast",

abstract = "![CDATA[Inhibitors of phosphodiesterase 4 (PDE4) are anti-inflammatory drugs that have been evaluated for the treatment of several inflammatory diseases. The major clinically useful members of this group are apremilast and roflumilast.]]",

keywords = "phosphodiesterases, anti-inflammatory agents",

author = "Graham, {Garry G.} and Pile, {Kevin D.}",

year = "2016",

doi = "10.1007/978-3-7643-8550-7_56",

language = "English",

isbn = "9783764385309",

pages = "1079--1084",

editor = "Parnham, {Michael J.}",

booktitle = "Compendium of Inflammatory Diseases",

publisher = "Springer",

}

TY - CHAP

T1 - Phosphodiesterase 4 inhibitors : apremilast and roflumilast

AU - Graham, Garry G.

AU - Pile, Kevin D.

PY - 2016

Y1 - 2016

N2 - ![CDATA[Inhibitors of phosphodiesterase 4 (PDE4) are anti-inflammatory drugs that have been evaluated for the treatment of several inflammatory diseases. The major clinically useful members of this group are apremilast and roflumilast.]]

AB - ![CDATA[Inhibitors of phosphodiesterase 4 (PDE4) are anti-inflammatory drugs that have been evaluated for the treatment of several inflammatory diseases. The major clinically useful members of this group are apremilast and roflumilast.]]

KW - phosphodiesterases

KW - anti-inflammatory agents

UR - http://handle.westernsydney.edu.au:8081/1959.7/uws:40012

U2 - 10.1007/978-3-7643-8550-7_56

DO - 10.1007/978-3-7643-8550-7_56

M3 - Chapter

SN - 9783764385309

SP - 1079

EP - 1084

BT - Compendium of Inflammatory Diseases

A2 - Parnham, Michael J.

PB - Springer

CY - Switzerland

ER -

Phosphodiesterase 4 inhibitors : apremilast and roflumilast

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this